Related Experiment Video

Updated: May 8, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

miR-335 inhibits small cell lung cancer bone metastases via IGF-IR and RANKL pathways

Meng Gong1, Junrong Ma, Ryan Guillemette

  • 1MD, PhD, Laboratory of Endocrinology and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 37 Guoxue Xiang, Chengdu, Sichuan 610041, People's Republic of China. xijieyu@hotmail.com.

Molecular Cancer Research : MCR
|August 23, 2013
PubMed
Abstract

Insights

Loss of microRNA-335 (miR-335) promotes bone metastasis in small cell lung cancer (SCLC) by increasing RANKL and IGF-IR. Restoring miR-335 may inhibit SCLC skeletal lesions.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Small cell lung cancer (SCLC) is an aggressive, incurable malignancy with a high propensity for bone metastasis.
  • Therapeutic targets are needed to prevent or slow SCLC metastatic progression to bone.
  • MicroRNAs (miRNAs) are key regulators of cellular processes and cancer progression.

Purpose of the Study:

  • To investigate the role of specific miRNAs in SCLC bone metastasis using preclinical models.
  • To identify potential therapeutic targets for SCLC skeletal metastases.

Main Methods:

  • Comparison of miRNA expression profiles between SCLC cell lines with different metastatic potentials (SBC-5 vs. SBC-3).
  • In vitro functional assays (migration, invasion, proliferation, osteoclastogenesis) upon miR-335 overexpression.
  • In vivo xenograft studies in mice to assess the impact of miR-335 on bone lesions.
  • Analysis of key bone metastasis mediators, including RANKL and IGF-IR.

Main Results:

  • SBC-5 cells, which metastasize to bone, showed reduced expression of miR-335 compared to SBC-3 cells.
  • Overexpression of miR-335 in SBC-5 cells significantly inhibited cell migration, invasion, proliferation, and osteoclast induction.
  • In vivo, miR-335 overexpression in SBC-5 xenografts markedly reduced osteolytic bone lesions.
  • miR-335 overexpression downregulated the expression of RANKL and IGF-IR, key mediators of bone metastasis.

Conclusions:

  • Loss of miR-335 is associated with and promotes SCLC skeletal metastatic lesions.
  • miR-335 may exert its function by regulating the RANKL and IGF-IR pathways.
  • These findings highlight miR-335 as a potential therapeutic target for SCLC with bone metastasis.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...